Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APGE |
---|---|---|
09:32 ET | 2161 | 38.57 |
09:34 ET | 100 | 37.72 |
09:36 ET | 600 | 38.25 |
09:38 ET | 288 | 38.005 |
09:39 ET | 2835 | 38.1 |
09:41 ET | 2535 | 38.19 |
09:45 ET | 100 | 38.025 |
09:48 ET | 700 | 37.87 |
09:52 ET | 12702 | 38.2 |
09:54 ET | 1754 | 38.175 |
09:56 ET | 100 | 38.16 |
09:57 ET | 200 | 37.95 |
09:59 ET | 700 | 37.6 |
10:01 ET | 1030 | 37.77 |
10:03 ET | 100 | 37.58 |
10:06 ET | 300 | 37.35 |
10:08 ET | 2800 | 37.425 |
10:12 ET | 809 | 37.675 |
10:14 ET | 800 | 37.99 |
10:15 ET | 1600 | 38.24 |
10:17 ET | 700 | 38.45 |
10:19 ET | 100 | 38.54 |
10:21 ET | 700 | 38.45 |
10:24 ET | 1000 | 38.325 |
10:26 ET | 700 | 38.22 |
10:28 ET | 1200 | 37.84 |
10:30 ET | 100 | 37.885 |
10:32 ET | 1297 | 37.95 |
10:37 ET | 1140 | 37.75 |
10:39 ET | 200 | 37.66 |
10:42 ET | 500 | 37.61 |
10:44 ET | 700 | 37.53 |
10:46 ET | 225 | 37.5 |
10:48 ET | 700 | 37.53 |
10:50 ET | 100 | 37.48 |
10:51 ET | 370 | 37.67 |
10:53 ET | 700 | 37.425 |
10:55 ET | 500 | 37.415 |
10:57 ET | 600 | 37.41 |
11:00 ET | 1874 | 37.205 |
11:02 ET | 1700 | 37.26 |
11:04 ET | 100 | 37.2 |
11:06 ET | 1800 | 37.31 |
11:08 ET | 319 | 37.27 |
11:09 ET | 100 | 37.27 |
11:11 ET | 2800 | 37.215 |
11:13 ET | 300 | 37.09 |
11:15 ET | 300 | 37.02 |
11:18 ET | 1281 | 37.015 |
11:20 ET | 400 | 36.95 |
11:22 ET | 302 | 36.88 |
11:24 ET | 595 | 36.91 |
11:26 ET | 3930 | 37.08 |
11:27 ET | 500 | 37.12 |
11:29 ET | 100 | 37.16 |
11:31 ET | 700 | 37 |
11:33 ET | 200 | 37 |
11:36 ET | 400 | 36.985 |
11:38 ET | 300 | 36.98 |
11:40 ET | 1300 | 36.83 |
11:42 ET | 300 | 36.795 |
11:44 ET | 400 | 36.715 |
11:45 ET | 1000 | 36.6 |
11:47 ET | 1100 | 37.035 |
11:49 ET | 100 | 37.04 |
11:51 ET | 100 | 37.13 |
11:54 ET | 200 | 37.22 |
11:56 ET | 300 | 37.22 |
11:58 ET | 1200 | 37.05 |
12:00 ET | 500 | 37.05 |
12:02 ET | 300 | 37.05 |
12:03 ET | 950 | 37.09 |
12:05 ET | 300 | 37.105 |
12:07 ET | 815 | 37.22 |
12:09 ET | 300 | 37.3 |
12:12 ET | 100 | 37.31 |
12:14 ET | 900 | 37.43 |
12:16 ET | 3000 | 37.62 |
12:18 ET | 2000 | 37.56 |
12:20 ET | 1136 | 37.82 |
12:21 ET | 800 | 37.73 |
12:25 ET | 306 | 37.72 |
12:27 ET | 400 | 37.73 |
12:30 ET | 862 | 37.68 |
12:32 ET | 400 | 37.61 |
12:34 ET | 300 | 37.5 |
12:36 ET | 100 | 37.49 |
12:38 ET | 1000 | 37.43 |
12:39 ET | 300 | 37.41 |
12:41 ET | 400 | 37.35 |
12:43 ET | 2300 | 37.32 |
12:48 ET | 600 | 37.308 |
12:50 ET | 700 | 37.31 |
12:52 ET | 800 | 37.29 |
12:54 ET | 1900 | 37.36 |
12:56 ET | 2906 | 37.33 |
12:57 ET | 3000 | 37.39 |
12:59 ET | 27400 | 37.5 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Apogee Therapeutics Inc | 2.2B | -18.3x | --- |
Structure Therapeutics Inc | 2.1B | -16.1x | --- |
Iovance Biotherapeutics Inc | 2.1B | -4.1x | --- |
CG Oncology Inc | 2.1B | -27.4x | --- |
Celldex Therapeutics Inc | 2.4B | -12.6x | --- |
Janux Therapeutics Inc | 2.0B | -31.4x | --- |
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immunology (I&I) indications with high unmet need. Its advanced programs are APG777 and APG808, which are developed for the treatment of AD and COPD, respectively. APG777 is a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) targeting IL-13. APG808 is an SQ extended half-life mAb targeting IL-4Rα. Its earlier-stage programs, APG990 and APG222, utilize advanced antibody engineering to target OX40L and both IL-13 and OX40L, which are developed for the treatment of AD. APG990 is an SQ extended half-life mAb targeting OX40L for the treatment of AD. APG222 is one or more extended half-life SQ antibodies targeting both IL-13 and OX40L, which has the potential to improve outcomes in AD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 58.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.04 |
Book Value | $7.86 |
P/E Ratio | -18.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.